
Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Up to 50% of ductal carcinoma in situ patients progress to a highly invasive stage of cancer

SPARROW balances time and cost when optimising molecular candidates to streamline

Histidine kinase is a crucial bacterial protein that regulates processes, including antibiotic resistance

The ability of oligonucleotides to modulate gene expression makes them an attractive modality for drugmakers

The autoimmune skin condition currently affects more than six million people in the US

The company combines machine learning, data generation and therapeutic product development

MOF activates the innate immune system through TLRs to provoke strong immune responses

The model found that the antibiotic doxycycline could interact with a common blood thinner, warfarin

Researchers have found that AI could be used to more accurately diagnose these patients

The high-resolution imaging method reveals new cells and structures in human brain tissue

The DNA scaffold carries multiple copies of a viral antigen which mimics virus structures